TSS
CTMX icon

Two Sigma Securities’s CytomX Therapeutics CTMX Stock Holding History

Two Sigma Securities’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,311
Closed -$107K – 1505
2025
Q2 		$107K Buy
+47,311
New +$76.3K 0.01% 1034
2023
Q2 		– Sell
-10,808
Closed -$16.3K – 2863
2023
Q1 		$16.3K Sell
10,808
-17,557
-62% -$39.7K ﹤0.01% 2393
2022
Q4 		$45.4K Buy
+28,365
New +$42K ﹤0.01% 2176
2022
Q2 		– Sell
-11,591
Closed -$31K – 2313
2022
Q1 		$31K Buy
+11,591
New +$44.5K ﹤0.01% 1929

Other funds holding CTMX

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Two Sigma Securities's CTMX Position: Q3 2025 in Review

Two Sigma Securities sold out of CytomX Therapeutics (CTMX) in Q3 2025, closing a stake of 47,311 shares — an estimated $107K sold.

Two Sigma Securities first reported a position in CTMX in Q1 2022 and held it in 4 quarters. The position peaked at $107K in Q2 2025. 103 funds tracked by Wall St. Rank hold CTMX as of Q3 2025.

  • Two Sigma Securities reported no remaining CytomX Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 47,311 CytomX Therapeutics shares in Q3 2025, an estimated $107K.
  • Two Sigma Securities first reported a position in CytomX Therapeutics in Q1 2022 and held it in 4 quarters.
  • Two Sigma Securities's CytomX Therapeutics position peaked at $107K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.